No CNS penetration (pGP substrates)
Optimization of H 1 Antagonists
• Poor receptor selectivity leads to side effects » Memory and cognition problems, confusion » Increased heart rate, blurred vision, urinary retention
• Long plasma half-life gives too long a duration of action (hangover) • Blood sample collection 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, 6, 8, 12, 16, 24, 36 and 48hr , , , , , , , , , , , , , , • Data Analysis 
Microdosing clinical study: Preclinical testing

• Pharmacology studies (non GLP)
» Demonstrated compounds to be pharmacologically active in animal model » Minimum effective dose in rats was >100-times the dose to be given to humans » Minimum effective dose in rats was 100 times the dose to be given to humans » All compounds passed in vitro criteria established for the program
• Limited Metabolism and PK data (non GLP)
» In vitro metabolism in human liver microsomes similar to the species used for p toxicology studies » IV/PO PK studies in animals (rodents and nonrodents) 
